期刊
BLOOD PURIFICATION
卷 22, 期 5, 页码 440-445出版社
KARGER
DOI: 10.1159/000080790
关键词
chronic renal injury reversal; renal replacement therapy; renin-angiotensin system; transforming growth factor-beta(1); bone morphogenic protein-7; hepatocyte growth factor
资金
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062987] Funding Source: NIH RePORTER
Progression of chronic nephropathies still represents a major challenge for clinical nephrologists. Specific therapies that prevent patients from requiring dialysis or transplantation are still not available. However, recent experimental studies have demonstrated that regression of advanced lesions in the kidney can be achieved. This review summarizes the recent therapeutic advances using experimental models that might translate into novel human therapies to prevent, or significantly delay, requirement of renal replacement therapy. Copyright (C) 2004 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据